| Mary Ellen Coy, MD | |
|
405 N Beaver St, Ste. 3, Flagstaff, AZ 86001-4500 | |
| (928) 226-7692 | |
| Not Available |
| Full Name | Mary Ellen Coy |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 405 N Beaver St, Flagstaff, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629122510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 36101 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Ellen Coy, MD 8545 W Mountain Shadows Dr, Flagstaff, AZ 86001-8186 Ph: (928) 226-7692 | Mary Ellen Coy, MD 405 N Beaver St, Ste. 3, Flagstaff, AZ 86001-4500 Ph: (928) 226-7692 |
News Archive
Researchers at the University of California, San Diego School of Medicine, led by Lucila Ohno-Machado, MD, PhD, chief of the Division of Biomedical Informatics in the Department of Medicine, have received two federal grants totaling more than $25 million to develop new ways to gather, analyze, use and share vast, ever-increasing amounts of biomedical information.
CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that Franciscan Alliance/St. Francis Heart Center in Indianapolis, Indiana is the first site to enroll a patient in the multi-center clinical trial of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation.
The Wall Street Journal reports on how the law might impact small businesses that employ young and healthy workers as well as whether the measure's new coverage might be too expensive for low-paid employees. Also in the news, a report concludes that U.S. consumers who purchase health insurance on the individual market saved $2.1 billion last year due to the overhaul's rules.
Enobia Pharma announced today the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six-month study will assess the safety, efficacy and pharmacokinetics of ENB-0040 in up to 12 children with HPP.
› Verified 3 days ago
Dr. Thomas J Gaughan, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-213-6411 | |
Dr. Adam Graff, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-213-6415 Fax: 928-213-6409 | |
Dr. Sara Faith Gibson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1300 S Yale St, Flagstaff, AZ 86001 Phone: 928-774-7128 | |
Dr. Mary L Delduca, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1515 N San Francisco St, Flagstaff, AZ 86001 Phone: 928-774-1538 Fax: 928-774-2801 | |
Matthew Alan Bond, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-213-6415 | |
Dr. Travis Clark Stiegler, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1501 S Yale St, Ste 250, Flagstaff, AZ 86001 Phone: 928-556-0707 Fax: 928-779-2223 | |
Alyssa Norman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-213-6415 |